Results 141 to 150 of about 482,727 (361)
Interaction of Heparin Active Factor and Egg-Yolk Lipoprotein. [PDF]
, 1954 Alex V. Nichols +2 more
openalex +1 more source
Advanced Science, EarlyView.This study develops a novel 3D human skeletal muscle organoid platform to study the immediate molecular effects of exercise‐like contractions. The model uncovers rapid proteomic and transcriptomic responses, resolving a fundamental paradox by demonstrating how exercise‐induced Lamtor1 coordinately activates both AMPK and mTORC1. Lamtor1 is a compelling
Ziyue Yao +9 more
wiley +1 more source
A New Extraction Procedure for the Preparation of Heparin [PDF]
, 1948 Olle Snellman +2 more
openalex +1 more source
Advanced Science, EarlyView.A computational approach to identify and characterize ligandable binding pockets on E3 ligases is presented. As a validation case, the first low‐micromolar small moleculesthat bind to the FBW7 E3 ligase are identified and confirmed to bind at the intended site.
Míriam Martínez‐Cartró +13 more
wiley +1 more source
CLEARING FACTOR, A HEPARIN-ACTIVATED LIPOPROTEIN LIPASE
, 1955 Edward D. Korn
openalex +1 more source
Further Investigations on the Reported Antianaphylactic Action of Heparin [PDF]
, 1930 C. I. Reed
openalex +1 more source
Advanced Science, EarlyView.Engineered neutrophil‐derived vesicles (SOD2‐Fer‐1@CVs) co‐delivering antioxidant and ferroptosis‐inhibitory agents enable inflammation‐targeted, ROS‐responsive therapy for ischemia–reperfusion injury in lung transplantation. Synergizing with ex vivo lung perfusion, this strategy alleviates oxidative stress and inflammation, restores vascular integrity,
Hao‐Xiang Yuan +10 more
wiley +1 more source